Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion type Assertion NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_head.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion evidence source_evidence_literature NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion SIO_000772 18459951 NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion wasDerivedFrom gad-20150221 NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.
- NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_assertion wasGeneratedBy ECO_0000203 NP122729.RAp-Sq6YCJCP9nsLOwjQLLrUP56NWUQzFzB6TJahv19Mg130_provenance.